No effect of roflumilast on cardiac repolarization in healthy subjects
R. Hermann, G. Lahu, A. Huennemeyer, D. Knoerzer, T. D. Bethke, W. Haverkamp (Konstanz, Berlin, Germany)
|  |
Experimental therapy with zinc-ions diminishes oxidant lung injury in rats
T. N. Preobrazhenskaya, E. S. Lebedeva (St. Petersburg, Russian Federation)
| |
Effect of neutrophil elastase inhibitor (ONO-5046) and gabexate mesilate on acid-induced lung injury in rats
S. Yoshikawa, K. Tsushima, T. Koizumi, K. Kubo (Matsumoto, Japan)
| |
Lipoxin A4 regulates bronchial epithelium responses to acid injury
C. Bonnans, K. Fukunaga, M. A. Levy, B. D. Levy (Boston, St Louis, United States Of America)
| |
Low systemic exposure of NVA237, an inhaled once-daily anticholinergic bronchodilator, in healthy humans
R. Thomas, E. Eltringham, R. Tansley, S. D. Snape (Merthyr Tydfil, Cambridge, United Kingdom)
| |
Pharmacokinetics (PK) and pharmacodynamics (PD) of tetomilast in stable COPD subjects
S. Mallikaarjun, S. Shoaf, P. Zhang, K. Mitsui, N. A. Molfino (Rockville, United States Of America)
| |
Tiotropium reduces subjectively reported sputum production in COPD
D. J. Powrie, T. M. Wilkinson, G. C. Donaldson, J. A. Wedzicha (London, United Kingdom)
| |
Effects of low dose inhaled carbon monoxide in patients with COPD
D. Bathoorn, D. J. Slebos, D. S. Postma, A. J. M. van Oosterhout, H. A. M. Kerstjens (Groningen, Netherlands)
| |
Is the hypoxemic effect of formoterol really linked to a shunt-like effect?
S. Centanni, F. Di Marco, P. Santus, M. Verga, A. Pistone, M. Cazzola (Milan, Naples, Italy)
| |
Effect of flavonoids extracted from Cleome Arabica on human neutrophil elastase activity
R. Kacem (Setif, Algeria)
| |
Relation of low serum lipid levels with coronary atherosclerosi in COPD patients
H. Ergen, S. Sarac, A. Saygili, Z. Arslan (Istanbul, Adiyaman, Turkey)
| |
Modulation of sputum gene expression in COPD by fluticasone/salmeterol
E. R. Sutherland, T. A. Moss, A. D. Stevens, J. Pak, R. J. Martin (Denver, United States Of America)
| |
Inhibition of human lung fibroblast functions by roflumilast N-oxide
S. Boero, M. Silvestri, F. Sabatini, A. Nachira, G. A. Rossi (Genoa, Italy)
| |
Inhibition of histone acetyltransferases attenuates cytokine and LPS-induced up-regulation of arginase in rat alveolar macrophages
M. Warnken, M. Heideking, S. Matthiesen, K. Racké (Bonn, Germany)
| |
Effects of TGF-beta and budesonide on MAPK phosphorylation, IL-6/IL-11 secretion, and cell proliferation in human lung fibroblasts
G. Pelaia, L. Gallelli, B. D‘Agostino, A. Vatrella, G. Cuda, D. Fratto, T. Renda, U. Galderisi, E. Piegari, N. Crimi, F. Rossi, M. Caputi, F. S. Costanzo, C. Vancheri, R. Maselli, S. A. Marsico (Catanzaro, Naples, Catania, Italy)
| |
Expression of transforming growth factors beta (1, 2, 3) and connective tissue growth factor in the peripheral lung from GOLD stage 1-2 COPD patients and smokers with normal lung function
G. Caramori, M. McLeish, A. Lewis, P. Monk, P. Casolari, K. Ito, K. F. Chung, I. M. Adcock, P. J. Barnes, A. Papi (Ferrara, Italy; Cambridge, London, United Kingdom)
| |
MUC5AC and MUC5B expression in central airways from non-smokers, smokers with normal lung function and GOLD stage 1 and 2 COPD patients
G. Caramori, P. Casolari, M. Saetta, S. Baraldo, K. Ito, L. M. Fabbri, P. J. Barnes, I. M. Adcock, G. Cavallesco, K. F. Chung, A. Papi (Ferrara, Padova, Modena, Italy; London, United Kingdom)
| |
Roflumilast but not methylprednisolone inhibited cigarette smoke-induced pulmonary inflammation in guinea pigs
M. F. Fitzgerald, D. Spicer, A. E. McAulay, L. Wollin, R. Beume (Stoke Poges, United Kingdom; Konstanz, Germany)
| |